Winona BBB and Consumer-Complaint Trends: What Women Should Know Before Signing Up

What Winona Is and How It Works

Winona is a direct-to-consumer telehealth company focused exclusively on menopause hormone therapy for women. You complete an online intake, a licensed physician reviews your history, and if appropriate you receive a prescription for compounded or FDA-approved hormone products shipped to your door. The subscription model means you are billed on a recurring cycle, which is one of the most common sources of friction that shows up in complaint data.

Understanding the business model matters before you evaluate any complaint. Cash-pay telehealth companies sit outside the insurance billing infrastructure, which removes one layer of consumer protection (insurer prior-auth review) while adding another vulnerability: you are responsible for monitoring your own renewal, dosage changes, and follow-up.

Winona's clinical focus is legitimate. Menopause hormone therapy is supported by The Menopause Society's 2023 position statement as the most effective treatment for vasomotor symptoms and is appropriate for most healthy women under 60 or within 10 years of menopause onset. The platform's existence fills a real gap: fewer than 25 percent of U.S. Women with significant menopause symptoms receive any treatment, often because of provider knowledge gaps or access barriers.

The question this article answers is not whether menopause telehealth is a good idea. It is whether Winona's specific complaint record should change how you approach signing up.

Winona's BBB Profile: What the Record Actually Shows

The Better Business Bureau is not a regulatory agency. Its ratings reflect complaint volume relative to company size, responsiveness to complaints, and accreditation fees paid, not clinical quality. Treat it as one data signal among several, not a definitive verdict.

As of mid-2025, Winona is not BBB-accredited. A company can receive a BBB letter-grade rating without paying for accreditation, and Winona appears in the BBB directory with a profile that includes both reviews and formal complaints. The absence of accreditation is not automatically a red flag for a telehealth startup, but it does mean Winona has not committed to the BBB's accreditation standards, which include a pledge to make good-faith efforts to resolve disputes.

What Complaint Categories Dominate

Across publicly visible BBB complaints for telehealth companies in the menopause space, three categories consistently dominate:

1. Billing and subscription renewal. Customers report being charged after attempting to cancel, or being enrolled in auto-renewal without clear disclosure at sign-up.
2. Shipping and product delays. Compounded medications require pharmacy preparation time. Delays of one to three weeks beyond the promised window appear in multiple complaints.
3. Difficulty reaching customer service. Complaints describe slow email response and no readily available phone support.

Winona's complaint profile follows this pattern. This does not distinguish it sharply from competitors in the cash-pay menopause telehealth space, but it does identify the specific friction points you should probe before subscribing.

Resolution Rate and Company Responses

The BBB tracks whether companies respond to complaints and whether the complainant considers the matter resolved. A high response rate with low resolution is actually worse than a moderate complaint volume that is fully resolved, because it suggests the company is performing damage control without addressing root causes. Review the response quality, not just the star count.

When you read Winona's responses to BBB complaints, look for whether they offer a concrete remedy (refund, re-shipment, confirmed cancellation confirmation email) or a generic apology. Specific remedies are the signal of an operationally functional company.

Complaint Trend Analysis: Billing and Subscription Issues

Billing complaints are the most clinically irrelevant yet practically significant category for any subscription health service.

Auto-Renewal Disclosures

Several Winona complainants describe signing up for what they understood to be a one-time or monthly plan, then finding themselves charged for a three-month or six-month supply they did not expect. Under the FTC's Negative Option Rule, companies must clearly disclose subscription terms before a consumer submits payment. The FTC finalized amendments to this rule in 2024 requiring easier cancellation pathways.

Before you subscribe to Winona or any telehealth menopause platform, take these specific steps:

• Screenshot the checkout page showing the billing interval and total charge.
• Read the cancellation policy in the terms of service, not the marketing page.
• Send a test email to customer support before purchase to gauge response time.

Compounding Pharmacy Lead Times

Winona uses compounding pharmacies for some of its formulations, including custom-dose estradiol creams and troches. Compounded medications are prepared per individual prescription, which means they cannot be pre-stocked. FDA regulations under 503A govern patient-specific compounding pharmacies, but the FDA does not approve individual compounded preparations for safety and efficacy the way it does manufactured drugs. This is not unique to Winona, but it is a pharmacologic reality women should understand: a compounded estradiol cream is not the same regulatory entity as FDA-approved Estrace or a transdermal patch.

Shipping complaints at Winona often spike around holidays and during high-demand periods. If you are already stable on a hormone regimen, a two-to-three-week shipping gap is more than an inconvenience; running out of estradiol abruptly can trigger a return of vasomotor symptoms within days.

Complaint Trend Analysis: Clinical Quality Concerns

Billing complaints tell you about operations. Clinical complaints tell you about safety. These are rarer but more important.

A small subset of Winona complaints on the BBB and on consumer review sites (Trustpilot, Reddit forums for perimenopause) describe:

• Prescriptions issued without what the patient considered an adequate clinical assessment.
• Difficulty adjusting doses when symptoms were not controlled.
• Inconsistent follow-up communication from the assigned physician.

These concerns are not unique to Winona. The cash-pay async telehealth model, where a physician reviews a written intake form rather than conducting a synchronous visit, has inherent limits for complex hormonal cases. ACOG Committee Opinion 798 acknowledges that telehealth can appropriately extend care access for many conditions but notes that clinical judgment about hormone therapy requires review of a full symptom history, blood pressure, and in some cases laboratory data.

When Async Prescribing May Not Be Enough

If any of the following apply to you, a purely asynchronous intake may not capture enough clinical nuance:

• You have a personal or first-degree family history of breast cancer, thromboembolism, or cardiovascular disease.
• Your symptoms are atypical (e.g., perimenopausal bleeding irregularities, severe mood symptoms, or significant sleep disruption without classic hot flashes).
• You are in the window of perimenopause where you may still be ovulating and need contraception alongside HRT.
• You have had a prior adverse reaction to hormone therapy.

In these situations, a synchronous telehealth visit with a menopause-trained clinician, or an in-person visit with a NAMS-certified menopause practitioner, offers a more thorough baseline assessment.

Is Winona Legit? Regulatory Standing and Prescriber Credentials

"Legit" means two things in this context: legally operating, and clinically sound. They are different questions.

Legal and Regulatory Standing

Winona operates through licensed physicians in states where it offers services. Physicians must hold state licenses in each state where they prescribe. Winona is not on the FDA's list of internet pharmacy warning letters, and LegitScript, the pharmacy verification service used by Google and payment processors, does not currently flag Winona as a rogue or unapproved pharmacy.

The compounding pharmacies Winona works with should be compliant with their state boards of pharmacy and, where applicable, accredited by the Pharmacy Compounding Accreditation Board (PCAB). You can ask Winona directly which pharmacy fulfills your prescription and then verify that pharmacy's standing independently.

Winona is not accredited by the National Committee for Quality Assurance (NCQA) or URAC, which are voluntary health plan and telehealth accreditation bodies. Most direct-to-consumer telehealth startups are not. That gap is worth knowing.

Clinical Legitimacy

Winona's formulary is grounded in evidence. Estradiol and progesterone are the hormones with the strongest evidence base in menopause management. The NAMS 2023 Menopause Hormone Therapy Position Statement affirms that for women under 60 without contraindications, the benefits of HRT for symptom management generally outweigh the risks. Winona prescribes within this framework.

Where Winona's clinical legitimacy gets more complicated is with compounded bioidentical hormones. The Menopause Society explicitly states that compounded bioidenticals are not recommended over FDA-approved options because they lack standardized dosing, quality control, and efficacy data. That does not make compounded hormones dangerous for every woman, but it is a real evidence limitation you deserve to know about.

Pregnancy, Lactation, and Contraception: A Required Safety Section

Menopause HRT is contraindicated in confirmed pregnancy. This is not a theoretical concern for all Winona's patients. Perimenopause can last four to ten years, and ovulation can occur sporadically even when cycles are irregular. A woman can become pregnant during perimenopause until she has had 12 consecutive months without a period (the clinical definition of menopause).

What This Means If You Are Perimenopausal

If you are still having any periods, even irregular ones, you may still be ovulating. Starting estradiol and progesterone for menopause symptom management does not provide contraception. You need a separate, reliable contraceptive method if pregnancy is not desired. Options compatible with HRT include:

• Low-dose combined oral contraceptives (which also treat perimenopausal symptoms and provide cycle control)
• A levonorgestrel IUD (which also provides endometrial protection)
• Barrier methods
• Surgical sterilization if your family is complete

Winona's intake should screen for this, but the asynchronous format means you must be accurate and complete in your self-reported history. Do not assume the platform's algorithm will flag ambiguous cycle data as a contraception concern.

Lactation

Systemic estrogen is generally avoided during breastfeeding because it can suppress milk production. Lactation data on transdermal estradiol is limited; what data exist suggest low transfer into breast milk, but the milk-suppression effect is the primary clinical concern. If you are postpartum and breastfeeding, Winona's standard HRT formulary is not appropriate. Postpartum hormonal management is a separate clinical conversation that requires an in-person or synchronous telehealth provider familiar with lactation medicine.

Teratogenicity

Progestogens used in HRT, including micronized progesterone and synthetic progestins, carry potential fetal risks if taken during pregnancy. The FDA's prescribing information for progesterone lists pregnancy as a contraindication for the menopause indication. If you discover you are pregnant while taking HRT through Winona or any platform, stop the medication and contact an OB-GYN immediately.

Who Winona Is Right For and Who It Is Not Right For

A Good Fit

You are likely a reasonable candidate for Winona if:

• You are post-menopausal (12 or more months without a period) or have well-documented perimenopausal symptoms confirmed by a prior in-person provider.
• You have no personal history of hormone-sensitive breast cancer, unexplained vaginal bleeding, active liver disease, or prior thromboembolism.
• Your primary symptoms are classic: hot flashes, night sweats, vaginal dryness, or sleep disruption directly tied to estrogen decline.
• You are geographically isolated or have limited access to a menopause-trained clinician.
• You have already been established on HRT and are looking for a more affordable or convenient ongoing prescription source.

Not the Right Fit

Consider a different pathway if:

• You are still having regular periods and have not had a menopause evaluation.
• You have a complex medical history including cardiovascular disease, clotting disorders, or a BRCA mutation.
• You are in the postpartum or lactation period.
• You need close monitoring, such as after an abnormal mammogram or with a new diagnosis of a hormone-sensitive condition.
• You have PCOS, which can complicate the hormonal picture considerably; PCOS does not prevent menopause but changes the hormonal trajectory in ways that require more nuanced assessment.

How Winona Compares to Other Menopause Telehealth Platforms

Winona is one of several cash-pay menopause telehealth platforms. Others include Midi Health, Alloy, Gennev (now part of Unified Women's Healthcare), and Evernow. Each has a different clinical model, formulary, and pricing structure.

"The proliferation of menopause telehealth is, on balance, a good thing for women's access to care, but the variation in clinical rigor between platforms is enormous," says Elena Vasquez, MD, OB-GYN and member of the WomanRx editorial board. "A woman deserves to know whether her platform uses asynchronous intake only or offers synchronous visits, which pharmacy fulfills her prescription, and what the follow-up protocol is if her symptoms are not controlled after 8 to 12 weeks."

Key differentiators to compare across platforms:

| Factor | What to Ask | |---|---| | Visit type | Async intake only, or synchronous video option? | | Formulary | FDA-approved products available, or compounded only? | | Follow-up | Structured re-evaluation at 8-12 weeks built in? | | Lab ordering | Can the platform order or review hormone labs? | | Cancellation | Month-to-month option without penalty? | | Pharmacy transparency | Named pharmacy disclosed upfront? |

Winona's model is primarily asynchronous, which is common in the sector. If you want a synchronous video visit as your initial evaluation, confirm that option exists before purchasing a subscription.

The Evidence Gap: What We Do Not Know About Telehealth-Delivered HRT

Women have been under-represented in trials evaluating telehealth delivery of hormone therapy specifically. The landmark Women's Health Initiative, which generated much of the safety data on HRT, was conducted in in-person settings with close clinical monitoring. Whether outcomes differ when HRT is initiated and managed through asynchronous telehealth without baseline labs or a physical exam is not yet known from prospective data.

This is a genuine evidence gap, not a reason to avoid telehealth menopause care entirely. It is a reason to be an informed patient: ask what your platform monitors, how, and how often.

The Menopause Society's 2023 position statement does not specifically address telehealth delivery models. ACOG's telehealth guidance supports expanding access but does not endorse any specific platform.

Five Specific Questions to Ask Winona Before You Pay

1. Which pharmacy will prepare my prescription, and can I verify its state licensure?
2. What is your protocol if my symptoms are not improved after 12 weeks on the initial dose?
3. Can I cancel my subscription at any time without a cancellation fee, and how do I do so?
4. If I need a dose adjustment, does that require a new visit fee or is it included?
5. Do you screen for contraindications to HRT including personal or family history of hormone-sensitive cancer, and what happens if I disclose a contraindication after sign-up?

These questions are not confrontational. They are the due diligence any responsible prescriber should welcome.